Adamas Pharmaceuticals (ADMS) Misses Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. VRTX
5. CHKP
6. ON
7. HNGE
8. INSP
9. AXSM
10. RXRX

Go back to Adamas Pharmaceuticals (ADMS) Misses Q2 EPS by 6c

Adamas Reports Second Quarter 2015 Financial Results

August 11, 2015 4:04 PM EDT

EMERYVILLE, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today reported financial results for the second quarter of 2015. The company reported a net loss attributable to common stockholders of $14.1 million, or $0.78 per share, for the quarter ended June 30, 2015. In the same period last year, the company reported net income attributable to common stockholders of $16.4 million, or $0.88 per share. Adamas ended the current quarter with $143.1 million in cash, cash equivalents, and available-for-sale securities compared to $158.7 million at December 31, 2014. This includes $8.5 million raised from the issuance of 472,141 shares of common stock through the quarter-end... More